Iovance Biotherapeutics, Inc. (0JDK.L)

USD 7.6

(-2.69%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 780.35 Million 663.98 Million 777.33 Million 768.45 Million 344.65 Million 480.82 Million
Total Current Assets 307.84 Million 479.11 Million 507.95 Million 636.1 Million 316.49 Million 475.37 Million
Cash And Short Term Investments 279.86 Million 471.84 Million 504.41 Million 629.43 Million 307.08 Million 468.52 Million
Cash and Cash Equivalents 114.88 Million 231.73 Million 78.22 Million 67.32 Million 13.96 Million 82.15 Million
Short Term Investments 164.97 Million 240.11 Million 426.18 Million 562.1 Million 293.11 Million 386.37 Million
Net Receivables 151 Thousand - - - - -
Inventory 10.37 Million - - - - -
Other Current Assets 17.45 Million 7.27 Million 3.54 Million 6.66 Million 9.41 Million 6.85 Million
Total Non-Current Assets 472.5 Million 184.86 Million 269.37 Million 132.35 Million 28.16 Million 5.44 Million
Net PPE 176.54 Million 178.24 Million 169.92 Million 113.91 Million 19.23 Million 2.68 Million
Good Will And Intangible Assets 229.25 Million - - - - -
Good Will - - - - - -
Intangible Assets 229.25 Million - - - - -
Long-Term Investments 66.43 Million 6.43 Million 97.67 Million 5.52 Million 5.45 Million -
Tax Assets -66.43 Million - - - - -
Other Non Current Assets 66.7 Million 189 Thousand 1.78 Million 12.91 Million 3.48 Million 2.76 Million
Other Assets - - 1.00 1.00 1.00 -
Total Liabilities 195.73 Million 164.34 Million 155.67 Million 111.96 Million 45.68 Million 14.62 Million
Total Current Liabilities 110.3 Million 91.48 Million 89.2 Million 54.87 Million 39.08 Million 14.39 Million
Account Payables 33.12 Million 26.6 Million 27.37 Million 13.51 Million 15.56 Million 2.73 Million
Tax Payables - - - - - -
Short Term Debt 7.77 Million 12.58 Million 5.05 Million 6.28 Million 7.25 Million -
Deferred Revenue 1.00 - - - - -
Other Current Liabilities 69.4 Million 52.29 Million 56.76 Million 35.07 Million 16.26 Million 11.65 Million
Total Non Current Liabilities 85.43 Million 72.85 Million 66.47 Million 57.08 Million 6.59 Million 230 Thousand
Long-Term Debt 1 Million 1 Million 1 Million 45.37 Million 4.24 Million -
Deferred Revenue Non Current 49.73 Million - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 17.34 Million -1 Million -1 Million 11.71 Million 2.35 Million 230 Thousand
Other Liabilities - - - 1.00 1.00 -
Total Equity 584.61 Million 499.63 Million 621.65 Million 656.49 Million 298.97 Million 466.19 Million
Stock Holders Equity 584.61 Million 499.63 Million 621.65 Million 656.49 Million 298.97 Million 466.19 Million
Common Stock 11 Thousand 8000.00 7000.00 6000.00 5000.00 5000.00
Retained Earnings -2.01 Billion -1.56 Billion -1.17 Billion -830.19 Million -570.61 Million -372.76 Million
Accumulated other comprehensive income 2.52 Million -902 Thousand -601 Thousand 19 Thousand 220 Thousand -42 Thousand
Common Stock Equity 584.61 Million 499.63 Million 621.65 Million 656.49 Million 298.97 Million 466.19 Million
Capital Lease Obligation 74.86 Million 71.85 Million 65.47 Million 45.37 Million 4.24 Million -
Total Investments 164.97 Million 246.54 Million 523.85 Million 567.63 Million 298.56 Million 386.37 Million
Total Debt 1 Million 85.44 Million 71.53 Million 51.65 Million 11.5 Million -
Net Debt -113.88 Million -146.28 Million -6.69 Million -15.67 Million -2.46 Million -82.15 Million

Balance Sheet Charts